Is C4 Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: CCCC) stock is to Hold CCCC stock.
Out of 3 analysts, 0 (0%) are recommending CCCC as a Strong Buy, 2 (66.67%) are recommending CCCC as a Buy, 0 (0%) are recommending CCCC as a Hold, 0 (0%) are recommending CCCC as a Sell, and 1 (33.33%) are recommending CCCC as a Strong Sell.
What is CCCC's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: CCCC) forecast ROE is N/A, which is considered weak.
What is CCCC's Price Target?
According to 3 Wall Street analysts that have issued a 1 year CCCC price target, the average CCCC price target is $10.00, with the highest CCCC stock price forecast at $17.00 and the lowest CCCC stock price forecast at $3.00.
On average, Wall Street analysts predict that C4 Therapeutics's share price could reach $10.00 by Aug 9, 2024. The average C4 Therapeutics stock price prediction forecasts a potential upside of 437.63% from the current CCCC share price of $1.86.
What is CCCC's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: CCCC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.08%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.